Evotec SE Executive Sells €576K in Shares
EVO sits 20% above its 52-week low of $2.308.
Summary
A key executive at Evotec SE, Dr. Cord Dohrmann, sold shares worth €576,720.00, signaling potential concerns amidst recent negative company developments.
Key Events · Ownership and Investor Activity · EVO
-
Executive Share Sale
Dr. Cord Dohrmann, a member of Evotec SE's managing body, disposed of shares with a total value of €576,720.00.
-
Transaction Details
The sale occurred on June 15, 2026, at a price of €4.81 per share on the Xetra exchange.
Analysis · EVO · Life Sciences
Dr. Cord Dohrmann, a member of Evotec SE's managing body, sold a significant amount of shares. This executive sale, valued at over half a million euros, comes amidst a period of negative news for the company, including a reduced outlook, a CFO change, and weak Q1 results. Such a transaction from a key executive can be interpreted as a lack of confidence, adding to existing investor concerns.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 29.7% of the 1528 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EVO was trading at $2.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1B. The 52-week trading range was $2.31 to $4.42. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.